Steven H. Collis Sells 21,350 Shares of AmerisourceBergen Corp. (ABC) Stock
AmerisourceBergen Corp. (NYSE:ABC) Chairman Steven H. Collis sold 21,350 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $93.54, for a total transaction of $1,997,079.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
AmerisourceBergen Corp. (NYSE ABC) traded up $0.35 during mid-day trading on Wednesday, hitting $94.39. 1,035,206 shares of the stock were exchanged, compared to its average volume of 1,700,000. AmerisourceBergen Corp. has a twelve month low of $71.90 and a twelve month high of $97.85. The company has a debt-to-equity ratio of 1.83, a current ratio of 0.91 and a quick ratio of 0.48. The firm has a market capitalization of $20,580.00, a price-to-earnings ratio of 58.27, a P/E/G ratio of 1.59 and a beta of 0.99.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a net margin of 0.27% and a return on equity of 56.29%. The business had revenue of $39.12 billion for the quarter, compared to analyst estimates of $40.10 billion. During the same quarter in the previous year, the business earned $1.30 earnings per share. The firm’s revenue was up 4.2% compared to the same quarter last year. equities research analysts predict that AmerisourceBergen Corp. will post 6.07 EPS for the current fiscal year.
ABC has been the subject of several recent research reports. Zacks Investment Research lowered shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Robert W. Baird reissued a “buy” rating and set a $96.00 target price on shares of AmerisourceBergen in a research note on Monday, November 6th. Cowen raised shares of AmerisourceBergen from a “market perform” rating to an “outperform” rating in a research note on Tuesday, October 10th. Mizuho set a $92.00 target price on shares of AmerisourceBergen and gave the company a “hold” rating in a research note on Tuesday, October 24th. Finally, Needham & Company LLC cut their target price on shares of AmerisourceBergen from $93.00 to $86.00 and set a “buy” rating for the company in a research note on Monday, November 6th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $95.26.
Hedge funds have recently added to or reduced their stakes in the company. Stephens Inc. AR increased its stake in AmerisourceBergen by 1.5% in the 2nd quarter. Stephens Inc. AR now owns 5,141 shares of the company’s stock valued at $486,000 after buying an additional 77 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in AmerisourceBergen by 0.7% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,329 shares of the company’s stock valued at $1,165,000 after buying an additional 80 shares during the period. Advisory Services Network LLC increased its stake in AmerisourceBergen by 2.4% in the 2nd quarter. Advisory Services Network LLC now owns 4,367 shares of the company’s stock valued at $413,000 after buying an additional 101 shares during the period. Thrivent Financial For Lutherans increased its stake in AmerisourceBergen by 3.0% in the 2nd quarter. Thrivent Financial For Lutherans now owns 6,250 shares of the company’s stock valued at $591,000 after buying an additional 180 shares during the period. Finally, Norinchukin Bank The increased its stake in AmerisourceBergen by 0.7% in the 2nd quarter. Norinchukin Bank The now owns 30,637 shares of the company’s stock valued at $2,896,000 after buying an additional 212 shares during the period. Institutional investors and hedge funds own 67.83% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Steven H. Collis Sells 21,350 Shares of AmerisourceBergen Corp. (ABC) Stock” was published by American Banking News and is the property of of American Banking News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2018/01/03/steven-h-collis-sells-21350-shares-of-amerisourcebergen-corp-abc-stock.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.